Allogeneic bone marrow transplantation for low-grade lymphoma

Blood

Volumn 92, Issue 5, 1998, Pages 1832-1836

  Van Besien, Koen ^b   Sobocinski, Kathleen A ^b   Rowlings, Philip A ^b   Murphy, Sandra C ^b   Armitage, James O ^b   Bishop, Michael R ^b   Chaekal, Ok Kyong ^b   Gale, Robert Peter ^b   Klein, John P ^b   Lazarus, Hillard M ^b   McCarthy Jr , Philip L ^b   Raemaekers, John M M ^b   Reiffers, Josy ^b   Phillips, Gordon L ^b   Schattenberg, Anton V M B ^b   Verdonck, Leo F ^b   Vose, Julie M ^b   Horowitz, Mary M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; METHOTREXATE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; FEMALE; HLA ANTIGENS; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LOW-GRADE; LYMPHOMA, MIXED-CELL, FOLLICULAR; LYMPHOMA, SMALL-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR FAMILY; RECURRENCE; REGISTRIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032170122     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Armitage JO: Drug therapy: Treatment of non-Hodgkin's lymphoma. N Engl J Med 328:1023, 1993
2. Portlock CS: Management of the low-grade non-Hodgkin's lymphomas. Semin Oncol 17:51, 1990
3. Romaguera JE, McLaughlin P, North L, Dixon D, Silvermintz KB, Garnsey LA, Velasquez WS, Hagemeister FB, Cabanillas F: Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. J Clin Oncol 9:762, 1991
4. Horning SJ: Treatment approaches to the low-grade lymphomas. Blood 83:881, 1994
5. Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B, Coral F, Nadler LM: Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 77:2524, 1991
6. Rohatiner AZS, Johnson PWM, Price CGA, Arnott SJ, Amess JAL, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J, MacCallum PK, Oza AM, Lister TA: Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177, 1994
7. Schouten HC, Bierman PJ, Vaughan WP, Kessinger A, Vose JM, Weisenburger DD, Armitage JO: Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 74:2579, 1989
8. Colombat P, Binet C, Linassier C, Desbois I, Lamagnere JP, Biron P, Philip T: High dose chemotherapy with autologous marrow transplantation in follicular lymphomas. Leuk Lymphoma 7:3, 1992 (suppl)
9. Bierman PJ, Vose JM, Anderson JR, Bishop MR, Kessinger A, Armitage JO: High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 15:445, 1997
10. Johnson PWM, Price CGA, Smith T, Cotter FA, Meerabux J, Rohatiner AZS, Young BD, Lister TA: Detection of cells bearing the t(14;18) translation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 12:798, 1994
11. Stone RM: Myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma: The price of progress? Blood 83:3437, 1994
12. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy. Blood 83:3780, 1994
13. Van Besien KW, Khouri IF, Giralt SA, McCarthy P, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Bellare N, Nath R, Romaguera JE, McLaughlin P, Korbling M, Deisseroth AB, Cabanillas FF, Champlin RE: Allogeneic bone marrow transplantation for refractory and recurrent low grade lymphoma: The case for aggressive management. J Clin Oncol 13:1096, 1995
14. Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED: Allogeneic bone marrow transplantation for non-lymphoblastic leukemia after first relapse. Blood 61:949, 1983
15. Lundberg JH, Hansen RM, Chitambar CR, Lawton CA, Gottlieb M, Anderson T, Ash RC: Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. J Clin Oncol 9:1848, 1991
16. Copelan EA, Kapoor N, Gibbins B, Tutschka PJ: Allogeneic marrow transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 5:47, 1990
17. Chopra R, Goldstone AH, Pearce R, Philip T, Petersen F, Appelbaum F, De Vol E, Ernst P: Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 10:1690, 1992
18. Mandigers C, Raemaekers J, Schattenberg A, Bogman J, Mensink E, de Witte T: Allogeneic bone marrow transplantation in patients with relapsed low-grade follicular non-Hodgkin's lymphoma. Blood 86:208a, 1995 (abstr, suppl 1)
19. Molina I, Nicolini F, Viret F, Pegourie-Bandelier B, Léger J, Sotto JJ: Allogeneic bone marrow transplantation for refractory and recurrent low grade non-Hodgkin's lymphoma. Blood 86:209a, 1995 (abstr, suppl 1)
20. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E and Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361, 1994
22. Przepiorka D, Weisdorf D, Martin P, Klingemann H-G, Beatty P, Hows J, Thomas ED: Consensus conference on GVHD grading. Bone Marrow Transplant 15:825, 1995
23. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb H-J, Rimm AA, Ringden O, Rozman C, Sobocinski KA, Zwaan FE and Bortin MM: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459, 1990
24. Attal M, Socie G, Molina L, Jouet JP, Pico J, Kuentz M, Blaise D, Milpied N, Ifrah N, Payen C, Tanguy ML: Allogeneic bone marrow transplantation for refractory and recurrent follicular lymphoma: A case-matched analysis with autologous transplantation from the French bone marrow transplant group registry data. Blood 20:1120a, 1997 (abstr, suppl 1)
25. Pleniket AJ, Ruiz de Elvira MC, Taghipour G, de Witte T, Tazelaar PJ, Carella A, Vernant JP, Schaefer UW, Cleeven M, Boogaerts MA, Gluckman E, Goldstone AH: Allogeneic transplantation for lymphoma produces a lower relapse rate than autologous transplantation but survival has not risen because of higher treatment-related mortality - A report of 764 cases from the EBMT lymphoma registry. Blood 1121a, 1997 (abstr, suppl 1)
26. Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F, Cummings G, Sensenbrenner LL: Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 84:1050, 1994
27. Jones RJ, Ambinder RF, Piantadosi S, Santos GW: Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649, 1991
28. van Besien KW, de Lima M, Giralt SA, Moore DF Jr., Chouri IF, Rondon G, Mehra R, Andersson BS, Dyer C, Cleary K, Przepiorka D, Gajewski JL, Champlin RE: Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect. Bone Marrow Transplant 19:977, 1997
29. Gribben JG, Freedrnan AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
30. Sharp JG, Joshi SS, Armitage JO, Bierman P, Coccia PF, Harrington DS, Kessinger A, Crouse DA, Mann SL, Weisenburger DD: Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood 79:1074, 1992
31. Williams CD, Goldstone AH, Pearce RM, Philip T, Hartmann O, Colombat P, Santini G, Foulard L, Gorin NC: Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. J Clin Oncol 14:2454, 1996
32. Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL Jr, Pavlovsky S, Peterson FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM: Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol 14:572, 1996